New pill tested for debilitating eye condition
Disease control
Recruiting now
This early-stage study is testing the safety of an oral medication called K9 for people with active Thyroid Eye Disease (TED). Up to 10 patients will take the pill twice daily for up to 24 weeks, with doctors closely monitoring for side effects. The study will also track changes …
Phase: PHASE1 • Sponsor: Peter Timoney • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC